ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33011-10mg |
|
56632-39-4 |
BHPI
|
0 | C21H17NO3 | |
GC33011-5mg |
|
56632-39-4 |
BHPI
|
0 | C21H17NO3 | |
GC33011-2mg |
|
56632-39-4 |
BHPI
|
0 | C21H17NO3 | |
GC33011-10mM(1mLinDMSO) |
|
56632-39-4 |
BHPI
|
0 | C21H17NO3 | |
GC33010-100mg |
|
2070009-64-0 |
GSK2110183 hydrochloride
|
0 | C18H17Cl3F2N4OS | |
GC33010-50mg |
|
2070009-64-0 |
GSK2110183 hydrochloride
|
0 | C18H17Cl3F2N4OS | |
GC33010-10mg |
|
2070009-64-0 |
GSK2110183 hydrochloride
|
0 | C18H17Cl3F2N4OS | |
GC33010-5mg |
|
2070009-64-0 |
GSK2110183 hydrochloride
|
0 | C18H17Cl3F2N4OS | |
GC33010-2mg |
|
2070009-64-0 |
GSK2110183 hydrochloride
|
0 | C18H17Cl3F2N4OS | |
GC33010-10mM(1mLinDMSO) |
|
2070009-64-0 |
GSK2110183 hydrochloride
|
0 | C18H17Cl3F2N4OS | |
GC33009-10mg |
|
— |
Deruxtecan analog
|
0 | — | |
GC33009-5mg |
|
— |
Deruxtecan analog
|
0 | — | |
GC33009-1mg |
|
— |
Deruxtecan analog
|
0 | — | |
GC33008-100mg |
|
1006378-90-0 |
p38 MAPK-IN-1
|
0 | C21H15F2N2O | |
GC33008-50mg |
|
1006378-90-0 |
p38 MAPK-IN-1
|
0 | C21H15F2N2O | |
GC33008-10mg |
|
1006378-90-0 |
p38 MAPK-IN-1
|
0 | C21H15F2N2O | |
GC33008-5mg |
|
1006378-90-0 |
p38 MAPK-IN-1
|
0 | C21H15F2N2O | |
GC33008-2mg |
|
1006378-90-0 |
p38 MAPK-IN-1
|
0 | C21H15F2N2O | |
GC33008-10mM(1mLinDMSO) |
|
1006378-90-0 |
p38 MAPK-IN-1
|
0 | C21H15F2N2O | |
GC33007-50mg |
|
192185-71-0 |
Tipifarnib S enantiomer ((S)-(-)-R-115777)
|
0 | C27H22Cl2N4O | |